Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Phenotypic polarization of macrophages in atherosclerosis.

Leitinger N, Schulman IG.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1120-6. doi: 10.1161/ATVBAHA.112.300173. Epub 2013 May 2. Review.

2.

Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes.

Chistiakov DA, Bobryshev YV, Nikiforov NG, Elizova NV, Sobenin IA, Orekhov AN.

Int J Cardiol. 2015 Apr 1;184:436-45. doi: 10.1016/j.ijcard.2015.03.055. Epub 2015 Mar 5. Review.

PMID:
25755062
3.

Macrophage phenotypes in atherosclerosis.

Colin S, Chinetti-Gbaguidi G, Staels B.

Immunol Rev. 2014 Nov;262(1):153-66. doi: 10.1111/imr.12218. Review.

PMID:
25319333
4.

Phenotypic modulation of macrophages in response to plaque lipids.

Adamson S, Leitinger N.

Curr Opin Lipidol. 2011 Oct;22(5):335-42. doi: 10.1097/MOL.0b013e32834a97e4. Review.

5.

Changes in transcriptome of macrophages in atherosclerosis.

Chistiakov DA, Bobryshev YV, Orekhov AN.

J Cell Mol Med. 2015 Jun;19(6):1163-73. doi: 10.1111/jcmm.12591. Epub 2015 May 13. Review.

6.

Macrophage subsets in atherosclerosis.

Chinetti-Gbaguidi G, Colin S, Staels B.

Nat Rev Cardiol. 2015 Jan;12(1):10-7. doi: 10.1038/nrcardio.2014.173. Epub 2014 Nov 4. Review.

PMID:
25367649
7.

Role of colony-stimulating factors in atherosclerosis.

Di Gregoli K, Johnson JL.

Curr Opin Lipidol. 2012 Oct;23(5):412-21. doi: 10.1097/MOL.0b013e328357ca6e. Review.

PMID:
22964991
8.

[Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].

Nikiforov NG, Kornienko VY, Karagodin VP, Orekhov AN.

Patol Fiziol Eksp Ter. 2015 Jul-Sep;(3):128-31. Review. Russian.

PMID:
26852607
9.

Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.

Rinne P, Silvola JM, Hellberg S, Ståhle M, Liljenbäck H, Salomäki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54. doi: 10.1161/ATVBAHA.113.302963. Epub 2014 May 1.

10.

A glimpse on the phenomenon of macrophage polarization during atherosclerosis.

Pello OM, Silvestre C, De Pizzol M, Andrés V.

Immunobiology. 2011 Nov;216(11):1172-6. doi: 10.1016/j.imbio.2011.05.010. Epub 2011 May 24. Review.

PMID:
21802768
11.

Atherosclerosis as an inflammatory disease.

Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G.

Curr Pharm Des. 2012;18(28):4266-88. Review.

PMID:
22390643
12.

Dectin-1 deficiency does not affect atherosclerosis development in mice.

Szilagyi K, Gijbels MJ, van der Velden S, Heinsbroek SE, Kraal G, de Winther MP, van den Berg TK.

Atherosclerosis. 2015 Apr;239(2):318-21. doi: 10.1016/j.atherosclerosis.2015.02.005. Epub 2015 Feb 7.

13.

Macrophages and Their Contribution to the Development of Atherosclerosis.

Bobryshev YV, Nikiforov NG, Elizova NV, Orekhov AN.

Results Probl Cell Differ. 2017;62:273-298. doi: 10.1007/978-3-319-54090-0_11. Review.

PMID:
28455713
14.

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.

Sastre C, Fernández-Laso V, Madrigal-Matute J, Muñoz-García B, Moreno JA, Pastor-Vargas C, Llamas-Granda P, Burkly LC, Egido J, Martín-Ventura JL, Blanco-Colio LM.

J Cell Mol Med. 2014 Apr;18(4):721-34. doi: 10.1111/jcmm.12221. Epub 2014 Jan 30.

15.

Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?

Jager NA, Teteloshvili N, Zeebregts CJ, Westra J, Bijl M.

Autoimmun Rev. 2012 Jul;11(9):621-6. doi: 10.1016/j.autrev.2011.11.002. Epub 2011 Nov 7. Review.

PMID:
22094710
16.

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA.

J Immunol. 2014 Nov 1;193(9):4344-55. doi: 10.4049/jimmunol.1400181. Epub 2014 Sep 26.

17.

Mechanisms that regulate macrophage burden in atherosclerosis.

Randolph GJ.

Circ Res. 2014 May 23;114(11):1757-71. doi: 10.1161/CIRCRESAHA.114.301174. Review.

18.

The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.

Fenyo IM, Gafencu AV.

Immunobiology. 2013 Nov;218(11):1376-84. doi: 10.1016/j.imbio.2013.06.005. Epub 2013 Jun 19.

PMID:
23886694
19.

Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.

Wolfs IM, Donners MM, de Winther MP.

Thromb Haemost. 2011 Nov;106(5):763-71. doi: 10.1160/TH11-05-0320. Epub 2011 Sep 22. Review.

PMID:
21947328
20.

Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation.

Sarrazy V, Sore S, Viaud M, Rignol G, Westerterp M, Ceppo F, Tanti JF, Guinamard R, Gautier EL, Yvan-Charvet L.

Cell Rep. 2015 Oct 6;13(1):132-44. doi: 10.1016/j.celrep.2015.08.068. Epub 2015 Sep 24.

Supplemental Content

Support Center